Health
Cancer drug lessens toxicity of protein from SARS-COV-2, find researchers – EdexLive
For the study, published in the journal in Cell & Bioscience, the team introduced each of these 27 SARS-CoV-2 genes in human cells and examined their toxicity
A team of researchers has identified the most toxic proteins made by SARS-COV-2 — the virus that causes COVID-19 — and then used an FDA-approved cancer drug to blunt the viral protein’s detrimental effects.
In their experiments in fruit flies and human cell lines, the team discovered the cell process that the virus hijacks, illuminating new potential candidate drugs that could be tested for treating severe Covid-19 disease patients.
“Our work suggests there is a way to prevent SARS-COV-2 from injuring…
Continue Reading
